Elsevier

The Lancet

Volume 370, Issue 9594, 6–12 October 2007, Pages 1199-1200
The Lancet

Comment
Inactivated influenza vaccines in the elderly—are you sure?

https://doi.org/10.1016/S0140-6736(07)61389-0Get rights and content

References (11)

There are more references available in the full text version of this article.

Cited by (21)

  • Deaths Preventable in the U.S. by Improvements in Use of Clinical Preventive Services

    2010, American Journal of Preventive Medicine
    Citation Excerpt :

    This number was summed across all deaths with and without the increased utilization of the intervention and the results were compared. No studies were found estimating the effect of Pap smear screening and colonoscopy on all-cause mortality, and there is substantial concern that currently available estimates of the effect of influenza vaccination on all-cause mortality are biased,8–10 so these three services were modeled using the cause-specific mortality model only. Because smoking increases mortality risks for many different categories of causes, smoking cessation was modeled using the all-cause mortality model only.

  • The cost-effectiveness of a universal influenza vaccination program for adults aged 50-64 years in Australia

    2008, Vaccine
    Citation Excerpt :

    However, in the US it was estimated that influenza is responsible for less than 10% of all-cause winter mortality among the elderly [46]. The inconsistency between these two figures has been widely noted, and the methodological problems associated with cohort studies suggested as the primary explanation [46–51]. This analysis has taken a conservative approach and used a vaccine efficacy for laboratory-confirmed influenza (74% [22]) against only excess hospitalisation and excess mortality attributable to influenza.

View all citing articles on Scopus
View full text